文献速递胸部肿瘤放疗放疗物理与技术

基于生物有效剂量的胸部再照射算法:在「禁区」中如何治疗的共同语言

An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone".
PubMed 文献 · Radiat Oncol · 2022-01-06

研究开发了一种算法,可将既往治疗计划的标称剂量自动转换为生物有效剂量(BED)三维分布图,并通过形变配准生成累积再照射BED图。在38例早期非小细胞肺癌复发再照射病例中验证了算法的剂量转换准确性,并报告了毒性事件。作者认为该方法可用于更精确地分析毒性剂量学预测因素并建立更准确的再照射正常组织约束。

要点

  • 算法可将标称剂量自动转换为BED值图,体素大小2.5 mm³,正常组织α/β取3。
  • 在38例再照射病例中验证了算法生成的BED图在每个体素上的剂量转换适当性。
  • 作者认为该方法可用于更精确地分析毒性剂量学预测因素并建立再照射正常组织约束。

核心结论

  • 该新型算法成功创建了基于BED值的逐体素复合治疗计划。
  • 该方法可用于更精确地分析毒性的剂量学预测因素,并为再照射建立更准确的正常组织约束。

研究设计与样本

  • 算法设计:将既往治疗计划的标称剂量自动转换为对应的BED值图,体素大小2.5 mm³,正常组织α/β取3(BED3)。
  • 每份计划转换为BED3剂量分布后,使用形变配准为接受两次治疗的患者创建累积再照射BED3计划。
  • 在38例再照射病例中进行原理验证分析,这些病例为早期非小细胞肺癌孤立性局部区域复发,初始接受立体定向消融放疗(SABR),随后接受再SABR或放化疗。

主要发现

  • 评估算法生成的图像显示,每个体素的物理剂量均被适当转换为BED。
  • 14例接受重复SABR的患者中,3级胸壁疼痛、肺炎和呼吸困难各1例(7%)。
  • 24例接受重复分次放疗的患者中,3级事件仅限于肺炎和呼吸困难各2例(8%)。
  • 提供了每例发生2-3级事件患者的复合BED3剂量学,可能有助于指导再照射中危及器官精确累积剂量阈值的建立。

临床怎么用

  • 作者认为该算法生成逐体素复合治疗计划的方法可用于更精确地分析毒性剂量学预测因素,并为再照射建立更准确的正常组织约束。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Re-irradiation (re-RT) is a technically challenging task for which few standardized approaches exist. This is in part due to the lack of a common platform to assess dose tolerance in relation to toxicity in the re-RT setting. To better address this knowledge gap and provide new tools for studying and developing thresholds for re-RT, we developed a novel algorithm that allows for anatomically accurate three-dimensional mapping of composite biological effective dose (BED) distributions from nominal doses (Gy). METHODS: The algorithm was designed to automatically convert nominal dose from prior treatment plans to corresponding BED value maps (voxel size 2.5 mm3 and α/β of 3 for normal tissue, BED3). Following the conversion of each plan to a BED3 dose distribution, deformable registration was used to create a summed composite re-irradiation BED3 plan for each patient who received two treatments. A proof-of-principle analysis was performed on 38 re-irradiation cases of initial stereotactic ablative radiotherapy (SABR) followed by either re-SABR or chemoradiation for isolated locoregional recurrence of early-stage non-small cell lung cancer. RESULTS: Evaluation of the algorithm-generated maps revealed appropriate conversion of physical dose to BED at each voxel. Of 14 patients receiving repeat SABR, there was one case each of grade 3 chest wall pain (7%), pneumonitis (7%), and dyspnea (7%). Of 24 patients undergoing repeat fractionated radiotherapy, grade 3 events were limited to two cases each of pneumonitis and dyspnea (8%). Composite BED3 dosimetry for each patient who experienced grade 2-3 events is provided and may help guide development of precise cumulative dose thresholds for organs at risk in the re-RT setting. CONCLUSIONS: This novel algorithm successfully created a voxel-by-voxel composite treatment plan using BED values. This approach may be used to more precisely examine dosimetric predictors of toxicities and to establish more accurate normal tissue constraints for re-irradiation.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Brooks ED, Wang X, De B, et al. An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone". Radiat Oncol. 2022. PMID: 34991637. doi:10.1186/s13014-021-01977-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。